Recently Released High Impact Publications

Can we use novel microRNA signatures to aid in prognostication for patients with acetaminophen-induced acute liver failure?
See new work from Dean Karvellas and the USALF Study Group team

Do taking ARBs/ACE inhibitors confer a survival advantage among patients infected with SARS-CoV-2?
See new work from the ARBs CORONA team including Oleksa Rewa

Can SARS-CoV-2 infection contribute risk to developing secondary HLH?
See interesting new work from Wendy Sligl and team

How do we assess the need for implementation of REBOA technology into high-volume trauma programs?
See new work from Matthew Douma, Sandy Widder, Nori Bradley and team

POCUS in COVID19?
See work on recommendations and protocols from Brian Buchannan and colleagues

We need to consider sex/gender-dependent differences in preclinical models of sepsis.
See new insights from Kimberly Macala and the Sepsis Canada National Preclinical Sepsis Platform team

Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection
New work from Wendy Sligl, Demetrios J. Kutsogiannis, Erika MacIntyre and colleagues